
    
      A total of 542 children aged between 6-59 months received either: (i) VA (control) or (ii) VA
      & Z (VAZ) or (iii) VA, Z & MV (VAZM). VA was delivered as a single dose while MV and Z were
      delivered daily. Malaria cases were managed by community health workers, who used rapid
      diagnostic test to confirm infection prior to treatment.
    
  